Recruitment for Covovax trials among children starts

Indigenously developed Zydus Cadila's needle-free Covid-19 vaccine ZyCoV-D has received emergency use authorisation from the drug regulator, making it the first vaccine to be administered in the age group of 12-18 years in the country.
Source: The Economic Times - Category: Consumer Health News Source Type: news